Daniel Karp
Fortuna: 927 757 $ al 31/05/2026
Fortuna: 927 757 $ al 31/05/2026
Daniel Karp is currently an Independent Director at Cartesian Growth Corp.
II since 2022 and Executive Vice President-Corporate Development at Organon & Co. Former positions include Independent Director at Cartesian Growth Corp., Vice President-Worldwide Business Development at Pfizer Inc. from 2016 to 2018, and Executive Vice President-Corporate Development at Biogen, Inc. from 2018 to 2020.
Education includes an undergraduate degree from Duke University and an MBA from The Wharton School of the University of Pennsylvania.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
ORGANON & CO. 0,03 % | 31/03/2026 | 69.547 ( 0,03 % ) | 927 757 $ | 31/05/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| CARTESIAN GROWTH CORPORATION II | Director/Miembro de la Junta | 01/05/2022 |
| ORGANON & CO. | Corporate Officer/Principal | - |
| Empresas | Cargo | Fin |
|---|---|---|
| BIOGEN INC. | Corporate Officer/Principal | 01/05/2020 |
| PFIZER INC. | Corporate Officer/Principal | 01/06/2018 |
| ALVARIUM TIEDEMANN A | Director/Miembro de la Junta | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 7 |
|---|---|
Pfizer Inc.
Pfizer Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development, manufacturing, marketing, sale and distribution of biopharmaceutical products & ingredients | Health Technology |
Biogen, Inc.
Biogen, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets therapies for neurological and neurodegenerative diseases | Health Technology |
Duke University
Duke University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Wharton School of the University of Pennsylvania
The Wharton School of the University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Cartesian Growth Corp.
Cartesian Growth Corp. Financial ConglomeratesFinance Operates as a blank check company | Finance |
Organon & Co.
Organon & Co. Pharmaceuticals: MajorHealth Technology Develops and delivers women health, trusted legacy brands and therapeutics | Health Technology |
Cartesian Growth Corp. II
Cartesian Growth Corp. II Financial ConglomeratesFinance Operates as a blank check company | Finance |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.